CORT
Corcept Therapeutics Incorporated (CORT)
$43
About Corcept Therapeutics Incorporated (CORT)
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
Details
Daily high
$46.17
Daily low
$45.04
Price at open
$45.39
52 Week High
$47.71
52 Week Low
$20.84
Market cap
4.7B
Dividend yield
0.00%
Volume
289
Avg. volume
1.0M
P/E ratio
40.30
Corcept Therapeutics Incorporated News
Details
Daily high
$46.17
Daily low
$45.04
Price at open
$45.39
52 Week High
$47.71
52 Week Low
$20.84
Market cap
4.7B
Dividend yield
0.00%
Volume
289
Avg. volume
1.0M
P/E ratio
40.30